These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21598386)

  • 1. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.
    Mlynarek AM; Balys RL; Su J; Hier MP; Black MJ; Alaoui-Jamali MA
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):910-8. PubMed ID: 17875858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y; Wu X; Liu X; Yan G; Xu C
    J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.
    Matta A; Tripathi SC; DeSouza LV; Grigull J; Kaur J; Chauhan SS; Srivastava A; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Michael Siu KW
    Int J Cancer; 2009 Sep; 125(6):1398-406. PubMed ID: 19548310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
    Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
    Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
    Sørensen BS; Horsman MR; Vorum H; Honoré B; Overgaard J; Alsner J
    Radiother Oncol; 2009 Sep; 92(3):443-9. PubMed ID: 19541378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
    Ralhan R
    Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry.
    Wu HY; Chang YH; Chang YC; Liao PC
    J Proteome Res; 2009 Jan; 8(1):380-9. PubMed ID: 19012429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.
    Mbeunkui F; Fodstad O; Pannell LK
    J Proteome Res; 2006 Apr; 5(4):899-906. PubMed ID: 16602697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.